Key result
Iron deficiency anemia linked to worse exercise capacity and quality of life in HFrEF.
Why the study?
The study was conducted to evaluate the effects of iron deficiency anaemia on the functional status of patients with heart failure with reduced ejection fraction.
Does iron deficiency anemia impair functional status in patients with HFrEF?
Cross-Sectional (n=320)
No
Does iron deficiency anemia impair functional status in patients with HFrEF?
Iron deficiency anemia is highly prevalent in HFrEF and is associated with significantly worse exercise capacity and quality of life.
Answers are grounded in this paper and cite their sources.
IDA associated with worse functional capacity and QoL in HFrEF; leaves open whether repletion improves outcomes in prospective trials.
Objective: To evaluate effects of iron deficiency anaemia on functional status of patients with heart failure with reduced ejection fraction (HfrEF). Study Design: Analytical cross-sectional study. Place and Duration of Study: Department of Medicine, Combined Military Hospital, Multan Pakistan, from Dec 2024 to Sep 2025. Methodology: A total of 320 adult patients with chronic HFrEF were enrolled through consecutive sampling. Functional status was assessed by New York Heart Association (NYHA) class, six-minute walk test (6MWT) and Kansas City Cardiomyopathy Questionnaire (KCCQ). Iron deficiency was defined as serum ferritin <100 µg/L or 100–299 µg/L with transferrin saturation (TSAT) <20%. Haemoglobin, ferritin and TSAT were measured. Comparisons between IDA (Group-A) and non-IDA (Group-B) groups were performed. Multivariable linear regression was applied to identify independent predictors of 6MWT distance. Results: Iron deficiency was observed in 196(61.3%) patients. Compared to non-deficient patients, those with IDA had lower mean haemoglobin (11.17±0.95 vs. 13.54±0.87 g/dL, p<0.001), ferritin (63.95 vs. 170.70 µg/L, p<0.001), TSAT (15.65% vs. 28.35%, p<0.001), 6MWT distance (280.98±44.56 vs. 303.32±42.51 m, p<0.001), and Kansas City Cardiomyopathy Questionnaire (KCCQ) scores (42.72±8.91 vs. 47.28±8.76, p<0.001). Regression analysis showed transferrin saturation (β=0.18, p=0.015) and haemoglobin (β=0.23, p=0.011) as independent predictors of six-minute walk test (6MWT) distance. Conclusion: IDA significantly impairs functional capacity and quality of life in patients with HFrEF. Routine screening and correction of iron deficiency should be integrated into heart failure management to improve outcomes.
No takes yet. Share an insight, caveat, or question.
Hassan et al. (2026) conducted a cross-sectional in Heart failure with reduced ejection fraction (HFrEF) (n=320). Iron deficiency anemia vs. Non-iron deficiency anemia was evaluated on Six-minute walk test (6MWT) distance (p=<0.001). Iron deficiency anemia significantly reduced six-minute walk test distance and Kansas City Cardiomyopathy Questionnaire scores compared to non-deficient patients with HFrEF.
Synapse has enriched 10 related papers. Consider them for comparative context: